Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

0.0%

0 terminated out of 15 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

33%

5 trials in Phase 3/4

Results Transparency

50%

6 of 12 completed with results

Key Signals

6 with results100% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (5)
Early P 1 (1)
P 1 (1)
P 2 (2)
P 3 (4)
P 4 (1)

Trial Status

Completed12
Unknown1
Recruiting1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT05660382Phase 3CompletedPrimary

Phase III Efficacy and Safety Study of Miconazole Oil for Otomycosis

NCT07535424Not ApplicableCompletedPrimary

Comparative Efficacy of Topical Clotrimazole Versus 2% Salicylic Acid in Otomycosis

NCT07295210Not ApplicableCompletedPrimary

Boric Acid Versus 10% Povidone Iodine Solution in Treatment of Otomycosis

NCT07152327Not ApplicableNot Yet RecruitingPrimary

Terbinafine Hydrochloride for the Treatment of Otomycosis

NCT03686384Phase 3CompletedPrimary

SVT-15652 Otic Solution for the Treatment of Otomycosis

NCT06431542Phase 4CompletedPrimary

Efficacy of Self Vs. Physician Application of Triamcinolone-Econazole in Otomycosis

NCT06530069RecruitingPrimary

Exploring the Risk Factors of Otomycosis: A Case-Control Study

NCT06339294Phase 1CompletedPrimary

Efficacy of Pyodine Soaked Gelfoam vs Single Topical Application of Clotrimazole in Otomycosis Treatment

NCT04432376Phase 2CompletedPrimary

Efficacy and Safety Study of Miconazole Oil Versus Vehicle on Fungal Infection of the Ear Canal (Otomycosis)

NCT03686397Phase 3CompletedPrimary

SVT-15652 Otic Solution for the Treatment of Otomycosis.

NCT03130738Phase 2CompletedPrimary

Dose-Ranging Study for Miconazole Oil for Treatment of Otomycosis

NCT04768829Early Phase 1CompletedPrimary

Antifungal Potential of Moringa Olifera Against Otomycosis

NCT04824261Not ApplicableUnknownPrimary

Effectiveness of 4% Boric Acid in Distilled Water Versus Clotrimazole Solution in Otomycosis Patients.

NCT01993823Phase 3CompletedPrimary

Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis

NCT01547221Not ApplicableCompletedPrimary

Effectiveness of 3% Boric Acid in 70% Alcohol Versus 1% Clotrimazole Solution in Otomycosis Patients

Showing all 15 trials

Research Network

Activity Timeline